Frequently Asked Questions in Locally Advanced SCCHN

More details
Frequently Asked Questions in Locally Advanced SCCHN

Past Events

Right Patient, Right Treatment, Right Time<br>Expanding the Reach of Targeted Therapy in Advanced NSCLC

Right Patient, Right Treatment, Right Time
Expanding the Reach of Targeted Therapy in Advanced NSCLC

An ACE Oncology Satellite Symposium to be held virtually in conjunction with the ESMO Asia Virtual Oncology Week 2021. Patient selection for...

Frequently Asked Questions on the Management of mCRC

Frequently Asked Questions on the Management of mCRC

Colorectal cancer is a complex and molecularly heterogeneous disease characterized by a diverse genomic landscape. Practicing physicians are commonly challenged by questions...

The Power of Precision Medicine in Advanced Non-Small Cell Lung Cancer: Focus on Targeting MET Alterations

The Power of Precision Medicine in Advanced Non-Small Cell Lung Cancer: Focus on Targeting MET Alterations

In the era of precision medicine, detecting genomic alterations is the first priority and guiding principle for personalized care. Advances in molecular...

Frequently Asked Questions on Managing NSCLC With Rare Oncogenic Drivers

Frequently Asked Questions on Managing NSCLC With Rare Oncogenic Drivers

The field of lung cancer is changing rapidly. The use of molecular testing and targeted therapy in oncogene-driven non-small cell lung cancer...

Managing Recurrent SCCHN in the Era of Immunotherapy:<br>Opportunities and Hurdles in Daily Clinical Practice

Managing Recurrent SCCHN in the Era of Immunotherapy:
Opportunities and Hurdles in Daily Clinical Practice

The management of recurrent/metastatic (R/M) squamous cell cancer of the head and neck (SCCHN) is evolving rapidly, and physicians often face clinical...

Virtual Molecular Tumor Board on Metastatic Colorectal Cancer:                Expert Advice on Managing Challenging Cases

Virtual Molecular Tumor Board on Metastatic Colorectal Cancer: Expert Advice on Managing Challenging Cases

The treatment landscape of metastatic colorectal cancer (mCRC) is changing rapidly. Advances in the molecular characterization of mCRC and increasing numbers of precision medicine...